Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1705卷 / 1期

关键词：

D O I：

10.1007/s40278-018-47032-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[21] Afatinib/erlotinibDevelopment of afatinib and erlotinib resistance in lung adenocarcinoma: case report
Reactions Weekly, 2018, 1726 (1) : 21 - 21
[22] AlectinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1682 (1) : 24 - 24
[23] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1754 (1) : 120 - 120
[24] CrizotinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2014, 1500 (1) : 15 - 15
[25] AfatinibAfatinib resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1656 (1) : 21 - 21
[26] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1633 (1) : 231 - 231
[27] ErlotinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2015, 1550 (1) : 89 - 89
[28] IcotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2020, 1809 (1) : 127 - 127
[29] Afatinib for the treatment of non-small cell lung cancer
Biello, Federica
Maggioni, Claudia
Rijavec, Erika
Genova, Carlo
Barletta, Giulia
Gualco, Elisa
Truini, Anna
Coco, Simona
Dal Bello, Maria Giovanna
Vanni, Irene
Alama, Angela
Boccardo, Francesco
Grossi, Francesco
EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (11): : 1357 - 1364
[30] Erlotinib/afatinibDevelopment of resistance in small cell lung cancer: case report
Reactions Weekly, 2015, 1560 (1) : 85 - 85

← 1 2 3 4 5 →